2 results
Approved WMOPending
Phase 1 - Primary Objective• To determine the maximum tolerated dose (MTD) and/or recommended phase 2 dose (RP2D) of single-agent MCLA-129 in patients with NSCLC, GC/GEJ adenocarcinoma, HNSCC or ESCC, with disease progression after prior therapy for…
Approved WMOCompleted
The primary objective of the present study is to examine the therapeutic effect of the Carbon Hand system on handgrip strength by patients with hand function problems, after using the glove for six weeks at home. Secondary objectives are related to…